Myeloma Management: Navigating Side Effects and Long-Term Care
Myeloma Management: Navigating Side Effects and Long-Term Care provides a clear, practical overview of myeloma, explaining what the disease is, how it is diagnosed, and why each person’s experience can differ. This webcast takes participants through today’s treatment options—from initial therapies to newer and more advanced approaches now available. The session highlights what patients can typically expect at each stage of treatment, including how decisions are made and how care is tailored to individual needs. The presentation also addresses common side effects, how they are managed, and what long-term care and monitoring can look like as myeloma often becomes a chronic condition. Attendees will leave with a better understanding of the treatment journey, the range of experiences patients may encounter, and the key questions to consider when navigating myeloma care. This free webcast is led by Anna Giulione, Clinical Research Nurse in Multiple Myeloma at Arthur Child J.E. Comprehensive Cancer Centre.

CAR T cell therapy Navigating the Canadian landscape

Blood Cancer: Seeing the Invisible to Prevent Recurrence

Mark Swain, MD - Fatigue in PBC - Who, How, Why and What to Do?

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t

Undiagnosed Diseases Network Grand Rounds - Vanderbilt Clinical Site - July 2026

THE FINAL DIRTY TRICK NARCISSISTS USE WHEN YOU STOP CARING | DR. RAMANI

Chichvarkin Saves Putin | Vitaly Portnikov

Understanding Myeloma: From Diagnosis to Treatment Foundations

Inpatient Seizure Management

Recent Advances in Multiple Myeloma with Dr. Dan Vogl

Immunotherapy and Blood Cancer

Unlocking Hope: The Role of Surgery in Pancreatic Cancer Treatment

Can a keto diet eliminate cancer growth? Dr. Thomas Seyfried says yes

Hjalmar Schacht: The Untold Story of Hitler’s Economic Mastermind Documentary

What We Know (and Still Don’t Know) About Genes and Blood Cancer

Empowering Nursing Practice Navigating the Treatment of DLBCL

Providing Inclusive Care for 2SLGBTQI+ people affected by a Blood Cancer In clinical practice new

Risk factors for endometrial cancer

All About CARVYKTI (Ciltacabtagene Autoleucel) | a Myeloma BCMA CAR T-Cell Therapy -Updated 2025

